Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Access/Strakan license agreement

Jan. 10, 1997

SIBIA Neurosciences/Aurora Biosciences drug discovery technology agreement

Jan. 10, 1997

Genetics Institute/Ontogeny functional genomics agreement

Jan. 10, 1997

Antibody-based collaborative agreement reached by CaT and Lilly

Jan. 10, 1997

Bristol-Myers Squibb/Cadus collaboration extended

Jan. 10, 1997

Sequana and Glaxo Wellcome alliance

Jan. 9, 1997

Progenitor's functional genomics program advances

Jan. 9, 1997

Drug discovery collaboration agreement signed by Houghten, Chugai

Jan. 9, 1997

Caliper Technologies technology useful in drug discovery

Jan. 8, 1997

Genzyme Transgenics, BASF forge agreement for transgenic production of biopharmaceuticals

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...